Psychedelics and Reimbursement in Europe
Join Lia Mix, CEO of Delphi, and Floris Wolswijk, Senior Policy and Research Partner at Delphi, for the third Delphi Insight Session on reimbursement pathways for psychedelic therapies in Europe.
Join Lia Mix, CEO of Delphi, and Floris Wolswijk, Senior Policy and Research Partner at Delphi, for the third Delphi Insight Session on reimbursement pathways for psychedelic therapies in Europe.
The second Delphi Insight Session features a conversation with Tyler Norris on the integration of psychedelics into the broader healthcare system, the challenges, and roadmap towards making this integration happen.
The first Delphi Insight Session – an introduction to Delphi, our work, and our vision for an integrated future.